TITLE

Harvard Bioscience, Inc. SWOT Analysis

PUB. DATE
December 2003
SOURCE
Harvard Bioscience, Inc. SWOT Analysis;December 2003, p1
SOURCE TYPE
SWOT Analysis
DOC. TYPE
Company Report
ABSTRACT
Presents an overview of Harvard Bioscience Inc., a company which designs and manufactures research enabling tools that aid the drug-development process at pharmaceutical and biotechnology companies, universities, and government research laboratories. Company overview, including revenues generated in fiscal year 2002, services provided, and principal businesses; Key facts, including contact information; Analysis of the company, including strengths, weaknesses, opportunities for improvement and threats.
ACCESSION #
13411568

 

Related Articles

  • Company Overview.  // Harvard Bioscience, Inc. SWOT Analysis;December 2003, p4 

    Presents an overview of Harvard Bioscience Inc., a company which designs and manufactures research enabling tools that aid the drug-development process at pharmaceutical and biotechnology companies, universities, and government research laboratories. Revenues generated in fiscal year 2002;...

  • Key Facts.  // Harvard Bioscience, Inc. SWOT Analysis;December 2003, p4 

    Presents key facts about Harvard Bioscience Inc., a company which designs and manufactures research enabling tools that aid the drug-development process at pharmaceutical and biotechnology companies, universities, and government research laboratories. Address and contact information; Revenues...

  • SWOT Analysis.  // Harvard Bioscience, Inc. SWOT Analysis;December 2003, p5 

    Provides a business analysis of Harvard Bioscience Inc., a company which designs and manufactures research enabling tools that aid the drug-development process at pharmaceutical and biotechnology companies, universities, and government research laboratories, focusing on its strengths,...

  • Company Overview.  // Teva Pharmaceutical Industries SWOT Analysis;December 2003, p4 

    Presents an overview of Teva Pharmaceutical Industries Ltd., which is a global healthcare company specializing in pharmaceuticals. Revenues generated in fiscal year 2002; Principal business offered, including human pharmaceuticals, active pharmaceutical ingredients and generic pharmaceuticals.

  • Teva Pharmaceutical Industries SWOT Analysis.  // Teva Pharmaceutical Industries SWOT Analysis;December 2003, p1 

    Presents an overview of Teva Pharmaceutical Industries Ltd., which is a global healthcare company specializing in pharmaceuticals. Company overview, including revenues generated in fiscal year 2002, services provided, and principal businesses; Key facts, including contact information; Analysis...

  • Key Facts.  // Teva Pharmaceutical Industries SWOT Analysis;December 2003, p4 

    Presents key facts about Teva Pharmaceutical Industries Ltd., which is a global healthcare company specializing in pharmaceuticals. Address and contact information; Revenues and financial year end data; Number of employees; SIC and NAICS codes; NASDAQ National Market ticker; Leading position in...

  • SWOT Analysis.  // Teva Pharmaceutical Industries SWOT Analysis;December 2003, p5 

    Provides a business analysis of Teva Pharmaceutical Industries Ltd., which is a global healthcare company specializing in pharmaceuticals, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths, including leading position in the U.S. generics...

  • SWOT Analysis.  // Taro Pharmaceuticals Industries Ltd. SWOT Analysis;Aug2007, p5 

    A business analysis of Taro Pharmaceutical Industries Ltd., which develops, manufactures and markets prescription and over-the-counter (OTC) pharmaceutical products is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths include...

  • Company Overview.  // Millennium Pharmaceuticals SWOT Analysis;Jun2007, p4 

    An overview of Millennium Pharmaceuticals Inc., a biopharmaceutical company that develops treatments and diagnostics primarily for four disease targets including cancer, metabolic diseases, cardiovascular and inflammation, is presented. Data is included on revenues generated in fiscal year ended...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics